ARS Pharmaceuticals's chart data is dated 2026-10-08. Recorded technical signals: Golden cross. There are 0 published signal records.
ARS Pharmaceuticals last closed at $4.56 (+4.59%) on 2026-10-08. Signals today: Golden cross. Listed on Nasdaq. Trailing 12 months PER is -2.1×. Its overall grade ranks 728 of 738 stocks in Healthcare.
About this company
ARS Pharmaceuticals last closed at $4.56 (+4.59%) on 2026-10-08. Signals today: Golden cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 728/738
Valuation grade C
Related stocks
- NeffyRelated theme
ARS의 대표 제품이자 비상용 아나필락시스 치료제 핵심 테마
- EpiPenCompetitor
아나필락시스 응급치료 시장의 대표 경쟁 제품
- PfizerCompetitor
에피네프린 자가주사기 시장에서 EpiPen 계열과 경쟁하는 대형 제약사
About ARS Pharmaceuticals
- What technical signals does ARS Pharmaceuticals (SPRY) have?
- ARS Pharmaceuticals current technical signals: golden cross (5_20, 0d ago).
- Is ARS Pharmaceuticals a cup-and-handle pattern?
- No. ARS Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for ARS Pharmaceuticals?
- Market cap: $450.75M. Trailing 12 months PER: -2.1×. Latest quarter PBR: 36.19×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about ARS Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.